Earnings Call Insights: Aytu BioPharma (AYTU) Q3 fiscal 2026 Management view "I'm very pleased to be speaking with you today following what has been an exciting first partial quarter of commercial launch activity for EXXUA" (CEO & Director Joshua Disbrow). "In Q3, more than 1,300 prescriptions were written for EXXUA" and "prescriptions increasing from about 200 in January to about 400 in February ...
Earnings Call Insights: Aytu BioPharma (AYTU) Q3 fiscal 2026 Management view "I'm very pleased to be speaking with you today following what has been an exciting first partial quarter of commercial launch activity for EXXUA" (CEO & Director Joshua Disbrow). "In Q3, more than 1,300 prescriptions were written for EXXUA" and "prescriptions increasing from about 200 in January to about 400 in February to over 700 in March" (CEO Disbrow). "In April, we saw over 920 prescriptions written" and "we shipped over 1,300 units shipped in April" (CEO Disbrow). "During the quarter, more than 450 unique prescribers wrote EXXUA prescriptions" and "our initial focus call universe is approximately 3,500 to 4,000 highly targeted prescribers" (CEO Disbrow). "ADHD net revenue was $9.1 million in the quarter compared to $15.4 million in the prior year period" and "the uptake of the third-party generic against Adzenys has been quite low... only achieving about 14% market share through 4-plus months of market availability" (CEO Disbrow). "Net revenue for the third quarter of fiscal 2026 was $12.4 million" and "for the quarter, we reported a net loss of $5.6 million or $0.53 net loss per share basic" (CFO, Corporate Secretary & Treasurer Ryan J. Selhorn). "On April 2, 2026, we filed a Form 8-K detailing warrant amendments" and "we reduced our warrant liability and increased stockholders' equity by $26.4 million" (CFO Selhorn). Outlook "While we are not providing formal guidance today" and "in the fourth quarter of this fiscal year, we are launching our online promotional campaigns... and should result in an increase in overall sales and marketing spend by $1 million to $2 million" (CFO Selhorn). "Depending on the success of these programs, we currently anticipate ongoing sales and marketing quarterly spend to range from $6 million to $7 million and G&A to range from $5 million to $5.3 million going forward" (CFO Selhorn). "We expect access, reimbursement, gross-to-net and refill dynamics to ...
Earnings Call Insights: Inovio Pharmaceuticals (INO) Q1 2026 Management View "These are very busy times at Inovio as we remain focused on achieving our top priority, advancing our lead candidate, INO-3107 through the regulatory process and toward its October 30 target PDUFA date." (CEO, President & Director Jacqueline Shea) "The FDA recently completed their standard mid-cycle review with no new si...
Earnings Call Insights: Inovio Pharmaceuticals (INO) Q1 2026 Management View "These are very busy times at Inovio as we remain focused on achieving our top priority, advancing our lead candidate, INO-3107 through the regulatory process and toward its October 30 target PDUFA date." (CEO, President & Director Jacqueline Shea) "The FDA recently completed their standard mid-cycle review with no new significant issues being raised and scheduled the late cycle review for the third quarter." (CEO, President & Director Shea) "We are continuing to advance our commercial readiness plans in anticipation of a potential U.S. approval in 2026, and we're planning to manage commercialization ourselves with the support of a contract sales organization." (Chief Commercial Officer Steven Egge) "We finished the first quarter of 2026 with $37.7 million in cash, cash equivalents and short-term investments compared to $58.5 million as of December 31, 2025." (Chief Financial Officer Peter Kies) Outlook "With the addition of the April public offering, we have extended our estimated cash runway into the first quarter of 2027 beyond the target PDUFA date of INO-3107." (Chief Financial Officer Kies) "This projection includes an operational net cash burn estimate of approximately $18 million for the second quarter of 2026." (Chief Financial Officer Kies) "The FDA recently completed their standard mid-cycle review with no new significant issues being raised and scheduled the late cycle review for the third quarter." (CEO, President & Director Shea) Compared with last quarter’s cash runway framing, management shifted from "We now estimate our cash runway to take us into fourth quarter 2026" (Chief Financial Officer Kies, Q4 2025) to "extended our estimated cash runway into the first quarter of 2027" (Chief Financial Officer Kies, Q1 2026). Financial Results Q1 2026 net loss was "$19.7 million or $0.28 per share basic and dilutive" vs. analyst EPS estimate (-$0.33) (Chief Financial Officer Kies; a...
This live article is freely available to our registered users. Please log in or create an account below. Unrivalled Xi-Trump summit analysis: get real-time updates and exclusive boots-on-the-ground reporting from our Beijing and Washington bureaus. Subscribe now with great savings to stay ahead. US President Donald Trump will meet Chinese President Xi Jinping today for a much-anticipated summit th...
This live article is freely available to our registered users. Please log in or create an account below. Unrivalled Xi-Trump summit analysis: get real-time updates and exclusive boots-on-the-ground reporting from our Beijing and Washington bureaus. Subscribe now with great savings to stay ahead. US President Donald Trump will meet Chinese President Xi Jinping today for a much-anticipated summit that could shape the next stage of rivalry between the world’s two superpowers. It is the first visit...
A year after Washington froze and then slashed foreign aid, development workers in the Philippines and across the region say the damage is still being felt, with job losses and abandoned projects continuing to threaten some of Asia’s most vulnerable groups. “On a personal level, it was the loss of income. But we lost a lot of critical projects in the country,” Sharon*, a former country representat...
A year after Washington froze and then slashed foreign aid, development workers in the Philippines and across the region say the damage is still being felt, with job losses and abandoned projects continuing to threaten some of Asia’s most vulnerable groups. “On a personal level, it was the loss of income. But we lost a lot of critical projects in the country,” Sharon*, a former country representative for a US-based organisation overseeing these projects in the Philippines, said in an...
At least gold glitters. Long before the first paper banknotes fluttered through the financial houses of Europe, the bustling markets of 11th century China birthed an unprecedented financial “innovation”: the use of paper currency. In the 1020s, burdened by the shortage of bronze coins and a rapidly expanding economy, merchants in the southwestern province of Sichuan began issuing paper promissory ...
At least gold glitters. Long before the first paper banknotes fluttered through the financial houses of Europe, the bustling markets of 11th century China birthed an unprecedented financial “innovation”: the use of paper currency. In the 1020s, burdened by the shortage of bronze coins and a rapidly expanding economy, merchants in the southwestern province of Sichuan began issuing paper promissory notes. This marked the genesis of jiaozi, the world’s earliest paper money. Soon, with the imperial...
The death of Ted Turner, who founded CNN in 1980 as the world’s first 24-hour television news channel, is a poignant reminder of the glory days of the fourth estate. CNN made day-and-night news coverage, including at the front line of battlefields, an everyday experience for many people. The rise of the internet and ever more channels of news delivery has enabled a global audience of news consumer...
The death of Ted Turner, who founded CNN in 1980 as the world’s first 24-hour television news channel, is a poignant reminder of the glory days of the fourth estate. CNN made day-and-night news coverage, including at the front line of battlefields, an everyday experience for many people. The rise of the internet and ever more channels of news delivery has enabled a global audience of news consumers, attuned to reports delivered from all around the world. This has turned the most successful news...
Blackstone Inc. -backed Bagmane Prime Office REIT is set to start trading in Mumbai on Thursday after raising $360 million in an initial public offering, a debut that will offer cues on investor appetite and the outlook for India’s equity capital markets. The REIT raised 34.05 billion rupees at 100 rupees per unit. The IPO included fresh issue of 23.90 billion rupees and an offer-for-sale of 10.15...
Blackstone Inc. -backed Bagmane Prime Office REIT is set to start trading in Mumbai on Thursday after raising $360 million in an initial public offering, a debut that will offer cues on investor appetite and the outlook for India’s equity capital markets. The REIT raised 34.05 billion rupees at 100 rupees per unit. The IPO included fresh issue of 23.90 billion rupees and an offer-for-sale of 10.15 billion rupees by Blackstone. The offering was subscribed 23 times, with retail investors bidding about six times the units on offer, underscoring strong demand for yield-generating assets. The Bengaluru-based developer is commanding a gray market premium of about 5%, according to IPOWatch, signaling cautious optimism ahead of the debut. A strong listing could encourage more real estate investment trusts to tap public markets and provide a lift to India’s broader IPO pipeline, which has slowed over the past two months as stocks turned more volatile. Investor interest has been supported by relatively strong returns from listed REITs, which have delivered yields of 15% to 26% over the past year, outperforming the benchmark Nifty index, which posted negative 3.5% returns over the same period, according to Bloomberg-compiled data. “REITs in India have been gaining traction, supported by stable cash flows from long-term commercial leases and their ability to deliver regular income distributions,” said Dharmesh Mehta , managing director and CEO of DAM Capital Advisors Ltd . “This makes them attractive to investors seeking predictable returns during periods of uncertainty.” Bagmane will be the sixth listed REIT in India, joining Knowledge Realty Trust , Mindspace Business Parks REIT , Brookfield India Real Estate Trust , Embassy Office Parks REIT and Nexus Select Trust . For the latest news on equity capital markets activity in the Asia-Pacific region, follow the channel or visit NI BFWECMAS . To subscribe to ECM Watch , Bloomberg’s daily roundup of news from around the region, c...
Shares of Nebius Group (NASDAQ: NBIS) popped on Wednesday after the cloud computing infrastructure provider boosted its artificial intelligence (AI)-fueled growth forecast. Image source: Getty Images. Nebius Group's revenue rocketed 684% higher year over year to $399 million in the first quarter. Continue reading
Shares of Nebius Group (NASDAQ: NBIS) popped on Wednesday after the cloud computing infrastructure provider boosted its artificial intelligence (AI)-fueled growth forecast. Image source: Getty Images. Nebius Group's revenue rocketed 684% higher year over year to $399 million in the first quarter. Continue reading